Skip to main content
Top
Published in: BMC Cancer 1/2015

Open Access 01-12-2015 | Research article

A qualitative study of women’s views on overdiagnosis and screening for thyroid cancer in Korea

Authors: Sang Hee Park, Bomyee Lee, Sangeun Lee, Eunji Choi, Eun-Bi Choi, Jisu Yoo, Jae Kwan Jun, Kui Son Choi

Published in: BMC Cancer | Issue 1/2015

Login to get access

Abstract

Background

The incidence of thyroid cancer in Korea has increased by about 25 % every year for the past 10 years. This increase is largely due to a rising incidence in papillary thyroid cancer, which is associated with an overdiagnosis of small tumors that may never become clinically significant. This study was conducted to explore Korean women’s understanding of overdiagnosis and to investigate changes in screening intention in response to overdiagnosis information.

Methods

Focus group interviews were conducted among women of ages 30–69 years, who are commonly targeted in Korea for cancer screening. Women were divided into four groups according to thyroid cancer screening history and history of thyroid disease. Of 51 women who were contacted, 29 (57 %) participated in the interviews.

Results

Prior awareness of thyroid cancer overdiagnosis was minimal. When informed about the risks of overdiagnosis, the participants were often surprised. Overcoming initial malcontent, many women remained skeptic about overdiagnosis and trusted in the advice of their physicians. Meanwhile, some of the study participants found explanations of overdiagnosis difficult to understand. Further, hearing about the risks of overdiagnosis had limited impact on the participants’ attitudes and intentions to undergo thyroid cancer screening, as many women expressed willingness to undergoing continued screening in the future.

Conclusion

A large majority of Korean women eligible for and had undergone thyroid cancer screening were unaware of the potential for overdiagnosis. Nevertheless, overdiagnosis information generally had little impact on their beliefs about thyroid cancer screening and their intentions to undergo future screening. Further research is needed to determine whether these findings could be generalized to the wider Korean population.
Literature
1.
go back to reference Jung KW, Won YJ, Kong HJ, Oh CM, Lee DH, Lee JS. Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2011. Cancer Res Treat. 2014;46(2):109–23.CrossRefPubMedPubMedCentral Jung KW, Won YJ, Kong HJ, Oh CM, Lee DH, Lee JS. Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2011. Cancer Res Treat. 2014;46(2):109–23.CrossRefPubMedPubMedCentral
2.
go back to reference Cho BY, Choi HS, Park YJ, Lim JA, Ahn HY, Lee EK, et al. Changes in the clinicopathological characteristics and outcomes of thyroid cancer in Korea over the past four decades. Thyroid. 2013;23(7):797–804.CrossRefPubMedPubMedCentral Cho BY, Choi HS, Park YJ, Lim JA, Ahn HY, Lee EK, et al. Changes in the clinicopathological characteristics and outcomes of thyroid cancer in Korea over the past four decades. Thyroid. 2013;23(7):797–804.CrossRefPubMedPubMedCentral
4.
go back to reference The Korea Central Cancer Regsitry. The national cancer center. Annual report of cancer statistics in Korea in 2011. Seoul: Ministry of Health and Welfare; 2013. The Korea Central Cancer Regsitry. The national cancer center. Annual report of cancer statistics in Korea in 2011. Seoul: Ministry of Health and Welfare; 2013.
5.
go back to reference Oh C-M, Jung K-W, Won Y-J, Shin A, Kong H-J, Lee J-S. Age-Period-Cohort Analysis of Thyroid Cancer Incidence in Korea. Cancer Res Treat. 2014; doi:10.4143/crt.2014.110. Oh C-M, Jung K-W, Won Y-J, Shin A, Kong H-J, Lee J-S. Age-Period-Cohort Analysis of Thyroid Cancer Incidence in Korea. Cancer Res Treat. 2014; doi:10.4143/crt.2014.110.
6.
go back to reference Ahn HS, Kim HJ, Welch HG. Korea’s thyroid-cancer “epidemic”--screening and overdiagnosis. N Engl J Med. 2014;371(19):1765–7.CrossRefPubMed Ahn HS, Kim HJ, Welch HG. Korea’s thyroid-cancer “epidemic”--screening and overdiagnosis. N Engl J Med. 2014;371(19):1765–7.CrossRefPubMed
7.
go back to reference Lee JH, Shin SW. Overdiagnosis and screening for thyroid cancer in Korea. Lancet. 2014;384(9957):1848.CrossRefPubMed Lee JH, Shin SW. Overdiagnosis and screening for thyroid cancer in Korea. Lancet. 2014;384(9957):1848.CrossRefPubMed
8.
go back to reference Bann DV, Goyal N, Camacho F, Goldenberg D. Increasing incidence of thyroid cancer in the commonwealth of Pennsylvania. JAMA Otolaryngol Head Neck Surg. 2014;140(12):1149–56.CrossRefPubMedPubMedCentral Bann DV, Goyal N, Camacho F, Goldenberg D. Increasing incidence of thyroid cancer in the commonwealth of Pennsylvania. JAMA Otolaryngol Head Neck Surg. 2014;140(12):1149–56.CrossRefPubMedPubMedCentral
10.
go back to reference Hersch J, Jansen J, Barratt A, Irwig L, Houssami N, Howard K, et al. Women’s views on overdiagnosis in breast cancer screening: a qualitative study. BMJ. 2013;346:f158.CrossRefPubMedPubMedCentral Hersch J, Jansen J, Barratt A, Irwig L, Houssami N, Howard K, et al. Women’s views on overdiagnosis in breast cancer screening: a qualitative study. BMJ. 2013;346:f158.CrossRefPubMedPubMedCentral
11.
go back to reference Waller J, Douglas E, Whitaker KL, Wardle J. Women’s responses to information about overdiagnosis in the UK breast cancer screening programme: a qualitative study. BMJ open. 2013;3(4):e002703.CrossRefPubMedPubMedCentral Waller J, Douglas E, Whitaker KL, Wardle J. Women’s responses to information about overdiagnosis in the UK breast cancer screening programme: a qualitative study. BMJ open. 2013;3(4):e002703.CrossRefPubMedPubMedCentral
12.
go back to reference Barbour R, Kitzinger J. Developing focus group research: politics, theory and practice. London: SAGE Publication Ltd.; 1999.CrossRef Barbour R, Kitzinger J. Developing focus group research: politics, theory and practice. London: SAGE Publication Ltd.; 1999.CrossRef
13.
go back to reference Morgan DL. Successful focus groups: Advancing the state of the Art. Newbury Park: SAGE Focus Edition; 1993.CrossRef Morgan DL. Successful focus groups: Advancing the state of the Art. Newbury Park: SAGE Focus Edition; 1993.CrossRef
14.
go back to reference Esserman LJ, Thompson Jr IM, Reid B. Overdiagnosis and overtreatment in cancer: an opportunity for improvement. JAMA. 2013;310(8):797–8.CrossRefPubMed Esserman LJ, Thompson Jr IM, Reid B. Overdiagnosis and overtreatment in cancer: an opportunity for improvement. JAMA. 2013;310(8):797–8.CrossRefPubMed
15.
go back to reference Junod B, Zahl PH, Kaplan RM, Olsen J, Greenland S. An investigation of the apparent breast cancer epidemic in France: screening and incidence trends in birth cohorts. BMC Cancer. 2011;11:401.CrossRefPubMedPubMedCentral Junod B, Zahl PH, Kaplan RM, Olsen J, Greenland S. An investigation of the apparent breast cancer epidemic in France: screening and incidence trends in birth cohorts. BMC Cancer. 2011;11:401.CrossRefPubMedPubMedCentral
17.
go back to reference Schwartz LM, Woloshin S, Fowler Jr FJ, Welch HG. Enthusiasm for cancer screening in the United States. JAMA. 2004;291(1):71–8.CrossRefPubMed Schwartz LM, Woloshin S, Fowler Jr FJ, Welch HG. Enthusiasm for cancer screening in the United States. JAMA. 2004;291(1):71–8.CrossRefPubMed
Metadata
Title
A qualitative study of women’s views on overdiagnosis and screening for thyroid cancer in Korea
Authors
Sang Hee Park
Bomyee Lee
Sangeun Lee
Eunji Choi
Eun-Bi Choi
Jisu Yoo
Jae Kwan Jun
Kui Son Choi
Publication date
01-12-2015
Publisher
BioMed Central
Published in
BMC Cancer / Issue 1/2015
Electronic ISSN: 1471-2407
DOI
https://doi.org/10.1186/s12885-015-1877-6

Other articles of this Issue 1/2015

BMC Cancer 1/2015 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine